| BYLD | JCPB | BYLD / JCPB | |
| Gain YTD | 7.487 | 7.626 | 98% |
| Net Assets | 295M | 8.57B | 3% |
| Total Expense Ratio | 0.17 | 0.38 | 45% |
| Turnover | 96.00 | 111.00 | 86% |
| Yield | 5.30 | 4.94 | 107% |
| Fund Existence | 12 years | 7 years | - |
| BYLD | JCPB | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 32% | 3 days ago 39% |
| Stochastic ODDS (%) | 1 day ago 49% | 3 days ago 43% |
| Momentum ODDS (%) | 1 day ago 41% | 3 days ago 59% |
| MACD ODDS (%) | 1 day ago 37% | 3 days ago 41% |
| TrendWeek ODDS (%) | 1 day ago 44% | 3 days ago 54% |
| TrendMonth ODDS (%) | 1 day ago 43% | 3 days ago 56% |
| Advances ODDS (%) | 4 days ago 42% | 18 days ago 52% |
| Declines ODDS (%) | 1 day ago 40% | 5 days ago 49% |
| BollingerBands ODDS (%) | 1 day ago 44% | 3 days ago 45% |
| Aroon ODDS (%) | 1 day ago 44% | 3 days ago 57% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| THISX | 91.23 | -0.47 | -0.51% |
| T. Rowe Price Health Sciences I | |||
| EPSPX | 25.70 | -0.28 | -1.08% |
| NYLI Epoch Global Equity Yield Class A | |||
| DESRX | 26.47 | -0.49 | -1.82% |
| DWS ESG Core Equity R | |||
| OSCAX | 22.77 | -0.53 | -2.27% |
| Invesco Main Street Small Cap A | |||
| TEFQX | 4.98 | -0.28 | -5.32% |
| Firsthand Technology Opportunities | |||
A.I.dvisor tells us that JCPB and EXE have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JCPB and EXE's prices will move in lockstep.
| Ticker / NAME | Correlation To JCPB | 1D Price Change % | ||
|---|---|---|---|---|
| JCPB | 100% | -0.05% | ||
| EXE - JCPB | 6% Poorly correlated | +0.69% | ||
| DAKT - JCPB | 2% Poorly correlated | +1.64% | ||
| CHRD - JCPB | -1% Poorly correlated | -1.56% |